Skip to content

Tissue-specific Effects of Insufficient Sleep

Tissue-specific Effects of Insufficient Sleep

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03437681
Enrollment
18
Registered
2018-02-19
Start date
2018-02-12
Completion date
2024-12-30
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Sleep, Blood Sugar

Brief summary

This study plans to learn more about how sleep loss impacts the way the body responds to sugar. This work will have important implications for development of treatments and countermeasures for people who are not able to get enough sleep for various reasons.

Detailed description

Participants will stay in the hospital for 6 days and will not be able to leave. Sleep habits will be measured for 7 days before the study. A research diet that is designed to maintain weight will be provided for 3 days before the study and during the study. Multiple tests will be performed, including metabolic testing and muscle and fat biopsies, both when participants first arrive and have had normal sleep and again after 4 nights of only 5 hours time in bed. The visit takes place at the Clinical Translational Research Center (CTRC) at the University of Colorado Denver, Anschutz Medical campus. It will take approximately 2 weeks to complete this study.

Interventions

BEHAVIORALInsufficient sleep

Four days of insufficient sleep

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The project is a within-subject consecutive design examining 18 healthy individuals after baseline and after 4 nights of insufficient sleep.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy, lean participants. 2. No regular physical activity (\<20 minutes/day). No exercise will be allowed for 3 days prior to study start. 3. Habitual sleep duration between 7-9.25h. Subjects must also be willing and able to keep a 9h time-in-bed schedule for 1 week prior to study admission. 4. Potential subjects must have lived at Denver altitude or higher for at least 3 months to inpatient study.

Exclusion criteria

1. Current or history of any clinically significant medical, psychiatric, or sleep disorder. 2. Use or history of any drugs, medications, supplements, caffeine, and alcohol. 3. Current or history of shiftwork in six months prior to laboratory study. 4. Travel more than one time zone in three weeks prior to laboratory study. 5. Blood donation in the 30 days prior to inpatient study.

Design outcomes

Primary

MeasureTime frameDescription
Change in insulin sensitivityOne weekInsulin sensitivity measured by hyperinsulinemic euglycemic clamp.

Secondary

MeasureTime frameDescription
Changes in macrovascular functionOne weekMacrovascular function will be assessed with flow-mediated dilation
Changes in microvascular functionOne weekMacrovascular function will be assessed with EndoPAT
Changes in cognitive abilitiesOne weekCognitive computer tests performed during study
Changes in circadian rhythmsOne weekSalivary dim-light melatonin offset will be assessed
Changes in metabolic tissue functionOne weekTissue biopsies will be performed

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026